- Iambic Therapeutics (Nasdaq: IAM) priced a $150M IPO at $16 and began trading Oct 15 — an AI drug-discovery listing testing public-market appetite for the sector. City Therapeutics (Nasdaq: CTY) upsized to $200M at $18 and started trading Oct 16. And Jio Platforms is targeting a ~$108B IPO in India, opening for subscription Oct 21 — the country's largest listing ever.
- S-1 filings worth reading, pricing nights, first-day pops and flops, lockup expiries that can pressure a stock, and how retail can actually get access — IPO ETFs, broker programs, and direct-listing mechanics. Biotech is leading this week's tape; the calendar broadens from here.
Useful?